In a fit of boundless national optimism, Peugeot and Renault (and a few years later Volvo) teamed up to make a new V8 for good power and performance. But that's not what the world got. We welcomed in ...
Fortress Biotech (FBIO) and its majority-owned subsidiary, Cyprium Therapeutics announced that Cyprium entered into a definitive asset purchase agreement to sell its Rare Pediatric Disease Priority ...
The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. Bavarian Nordic has reached an agreement to sell a priority review voucher (PRV) ...
While the price of just about everything has increased over the last six years in the U.S., the same can’t be said for the cost of an FDA priority review voucher. Just ask Sarepta Therapeutics. Since ...
TALLAHASSEE, FL / ACCESSWIRE / February 5, 2021 / Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other ...
Millions of Americans report that they are unable to fill their prescriptions or are not taking their medications as prescribed because they cannot afford them, generating bipartisan interest in ...
DENVER, Aug. 28, 2019 /PRNewswire/ — Platte River Equity (“Platte River”) is pleased to announce the sale of its portfolio company, PRV Metals, LLC (“PRV Metals” or the “Company’), to Tinicum L.P.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results